Matches in SemOpenAlex for { <https://semopenalex.org/work/W4300962021> ?p ?o ?g. }
- W4300962021 abstract "Multisystem inflammatory syndrome in children (MIS-C) is a rare, severe complication of COVID-19. A better knowledge of immunological, cellular, and genetic characteristics of MIS-C could help better understand the pathogenesis of the disease and contribute to identifying specific diagnostic biomarkers and develop targeted therapies. We studied 37 MIS-C children at hospital admission and 24 healthy controls analyzing serum cytokines (IFN-α, IFN-β, IFN-γ, IL-6, IL-10, IL-17A, IL-12p70 and TNF), lymphocyte populations by flow cytometry and 386 genes related to autoimmune diseases, autoinflammation and primary immunodeficiencies by NGS. MIS-C patients showed a significant increase of serum IFNγ (despite a significant reduction of activated Th1) and ILs, even if with a great heterogeneity among patients, revealing different pathways involved in MIS-C pathogenesis and suggesting that serum cytokines at admission may help to select the inflammatory pathways to target in each patient. Flow cytometry demonstrated a relevant reduction of T populations while the percentage of B cell was increased in agreement with an autoimmune pathogenesis of MIS-C. Genetic analysis identified variants in 34 genes and 83.3% of patients had at least one gene variant. Among these, 9 were mutated in more patients. Most genes are related to autoimmune diseases like ATM, NCF1, MCM4, FCN3, and DOCK8 or to autoinflammatory diseases associated to the release of IFNγ like PRF1, NOD2, and MEF. Thus, an incomplete clearance of the Sars-CoV2 during the acute phase may induce tissue damage and self-antigen exposure and genetic variants can predispose to hyper-reactive immune dysregulation events of MIS-C-syndrome. Type II IFN activation and cytokine responses (mainly IL-6 and IL-10) may cause a cytokine storm in some patients with a more severe acute phase of the disease, lymphopenia and multisystemic organ involvement. The timely identification of such patients with an immunocytometric panel might be critical for targeted therapeutic management." @default.
- W4300962021 created "2022-10-04" @default.
- W4300962021 creator A5012569202 @default.
- W4300962021 creator A5015496746 @default.
- W4300962021 creator A5033834297 @default.
- W4300962021 creator A5039510130 @default.
- W4300962021 creator A5042973549 @default.
- W4300962021 creator A5045289271 @default.
- W4300962021 creator A5050025219 @default.
- W4300962021 creator A5052432715 @default.
- W4300962021 creator A5056369325 @default.
- W4300962021 creator A5065906115 @default.
- W4300962021 creator A5067909605 @default.
- W4300962021 creator A5075279569 @default.
- W4300962021 creator A5085049536 @default.
- W4300962021 date "2022-10-03" @default.
- W4300962021 modified "2023-10-18" @default.
- W4300962021 title "MIS-C: A COVID-19-as sociated condition between hypoimmunity and hyperimmunity" @default.
- W4300962021 cites W1484977079 @default.
- W4300962021 cites W1934255147 @default.
- W4300962021 cites W2149610558 @default.
- W4300962021 cites W2620810594 @default.
- W4300962021 cites W2883909047 @default.
- W4300962021 cites W2905452503 @default.
- W4300962021 cites W2951374571 @default.
- W4300962021 cites W2985711157 @default.
- W4300962021 cites W3004242928 @default.
- W4300962021 cites W3008229575 @default.
- W4300962021 cites W3023564401 @default.
- W4300962021 cites W3024822200 @default.
- W4300962021 cites W3025256562 @default.
- W4300962021 cites W3032824264 @default.
- W4300962021 cites W3034241701 @default.
- W4300962021 cites W3034358290 @default.
- W4300962021 cites W3034537415 @default.
- W4300962021 cites W3037459555 @default.
- W4300962021 cites W3046404304 @default.
- W4300962021 cites W3080670851 @default.
- W4300962021 cites W3084924559 @default.
- W4300962021 cites W3087862874 @default.
- W4300962021 cites W3111853143 @default.
- W4300962021 cites W3112665036 @default.
- W4300962021 cites W3115391003 @default.
- W4300962021 cites W3132267494 @default.
- W4300962021 cites W3154836057 @default.
- W4300962021 cites W3165279931 @default.
- W4300962021 cites W3169462898 @default.
- W4300962021 cites W3171562490 @default.
- W4300962021 cites W3185045052 @default.
- W4300962021 cites W3190164270 @default.
- W4300962021 cites W3195409665 @default.
- W4300962021 cites W3199631438 @default.
- W4300962021 cites W4213211303 @default.
- W4300962021 cites W4220719055 @default.
- W4300962021 cites W4221049317 @default.
- W4300962021 cites W4224261859 @default.
- W4300962021 cites W4225524116 @default.
- W4300962021 doi "https://doi.org/10.3389/fimmu.2022.985433" @default.
- W4300962021 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36263058" @default.
- W4300962021 hasPublicationYear "2022" @default.
- W4300962021 type Work @default.
- W4300962021 citedByCount "4" @default.
- W4300962021 countsByYear W43009620212023 @default.
- W4300962021 crossrefType "journal-article" @default.
- W4300962021 hasAuthorship W4300962021A5012569202 @default.
- W4300962021 hasAuthorship W4300962021A5015496746 @default.
- W4300962021 hasAuthorship W4300962021A5033834297 @default.
- W4300962021 hasAuthorship W4300962021A5039510130 @default.
- W4300962021 hasAuthorship W4300962021A5042973549 @default.
- W4300962021 hasAuthorship W4300962021A5045289271 @default.
- W4300962021 hasAuthorship W4300962021A5050025219 @default.
- W4300962021 hasAuthorship W4300962021A5052432715 @default.
- W4300962021 hasAuthorship W4300962021A5056369325 @default.
- W4300962021 hasAuthorship W4300962021A5065906115 @default.
- W4300962021 hasAuthorship W4300962021A5067909605 @default.
- W4300962021 hasAuthorship W4300962021A5075279569 @default.
- W4300962021 hasAuthorship W4300962021A5085049536 @default.
- W4300962021 hasBestOaLocation W43009620211 @default.
- W4300962021 hasConcept C104317684 @default.
- W4300962021 hasConcept C126322002 @default.
- W4300962021 hasConcept C203014093 @default.
- W4300962021 hasConcept C2779134260 @default.
- W4300962021 hasConcept C2780942790 @default.
- W4300962021 hasConcept C54355233 @default.
- W4300962021 hasConcept C553184892 @default.
- W4300962021 hasConcept C71924100 @default.
- W4300962021 hasConcept C86803240 @default.
- W4300962021 hasConceptScore W4300962021C104317684 @default.
- W4300962021 hasConceptScore W4300962021C126322002 @default.
- W4300962021 hasConceptScore W4300962021C203014093 @default.
- W4300962021 hasConceptScore W4300962021C2779134260 @default.
- W4300962021 hasConceptScore W4300962021C2780942790 @default.
- W4300962021 hasConceptScore W4300962021C54355233 @default.
- W4300962021 hasConceptScore W4300962021C553184892 @default.
- W4300962021 hasConceptScore W4300962021C71924100 @default.
- W4300962021 hasConceptScore W4300962021C86803240 @default.
- W4300962021 hasFunder F4320322218 @default.
- W4300962021 hasFunder F4320331528 @default.
- W4300962021 hasLocation W43009620211 @default.
- W4300962021 hasLocation W43009620212 @default.